Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 12.04.19 in Vol 7, No 4 (2019): April

Preprints (earlier versions) of this paper are available at http://preprints.jmir.org/preprint/10809, first published Apr 18, 2018.

This paper is in the following e-collection/theme issue:

    Original Paper

    Quality of Blood Pressure Tracking Apps for the iPhone: Content Analysis and Evaluation of Adherence With Home Blood Pressure Measurement Best Practices

    1Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada

    2Saskatchewan Health Authority, Regina Region, Regina, SK, Canada

    Corresponding Author:

    Mark J Makowsky, BSP, PharmD

    Faculty of Pharmacy & Pharmaceutical Sciences

    University of Alberta

    3-171 Edmonton Clinic Health Academy

    11405 87 Avenue

    Edmonton, AB, T6G 1C9

    Canada

    Phone: 1 (780) 492 1735

    Fax:1 (780) 492 1217

    Email: makowsky@ualberta.ca


    ABSTRACT

    Background: Blood pressure (BP) tracking apps may aid in hypertension (HTN) self-management, but app quality may be problematic.

    Objective: This study aimed to develop a content-dependent rating system for BP tracking apps and systematically evaluate BP tracking features, content-independent quality, functional characteristics, and educational comprehensiveness of English language iPhone apps developed with the primary purpose of tracking a consumer’s BP measurements.

    Methods: We created a 28-item checklist reflecting overall app quality and a simplified 2-item checklist to assess adherence with home BP monitoring best practices. Apps with educational information were evaluated for comprehensiveness on a 7-point scale and for consistency with evidence-based guidelines. Higher scores represent better quality and comprehensiveness. We searched the Canadian App Store on June 28, 2016, using the keywords hypertension and blood pressure. A total of 2 reviewers independently assessed apps according to the standardized template. We determined if paid apps, educational apps, or those rated ≥4 stars were of higher quality.

    Results: Of the 948 apps screened, 62 met the inclusion criteria. The mean overall quality score was 12.2 (SD 4.6, out of 28) and 6 apps (10%, 6/62) met the home BP monitoring best practice criteria. In all, 12 apps contained educational content (mean comprehensiveness 2.4, SD 1.6 out of 14), most commonly, background information on HTN. Apps with educational content (mean 15.1, SD 3.8 vs 11.8, SD 4.8; P=.03) or a ≥4 star rating (median 19, interquartile range [IQR] 15-20, vs 12, IQR 9-15; P=.02) had higher overall quality.

    Conclusions: The BP tracking apps reviewed had variable quality and few met the home BP monitoring best practice criteria. When deciding to recommend a specific BP tracking app, we suggest clinicians should evaluate whether the app allows input of duplicate BP readings in the morning and evening for at least seven days and presents the mean BP value for user-specified dates. Greater attention to home BP measurement best practices is required during app development.

    JMIR Mhealth Uhealth 2019;7(4):e10809

    doi:10.2196/10809

    KEYWORDS



    Introduction

    Background

    High blood pressure (BP) affects approximately 31% of adults globally [1] and affects 23% of Canadian adults [2]. In 2010, hypertension (HTN) was the leading cause of death and disability-adjusted life years worldwide; in 2015, high systolic BP accounted for 10.7 million deaths and 211.8 million disability-adjusted life years [3,4]. Lifestyle modification and medication management effectively reduce cardiovascular risk in patients with HTN. For example, a multicomponent intervention promoting increased physical activity, weight loss, reduced sodium intake, and the Dietary Approaches to Stop Hypertension (DASH) diet, reduced the HTN prevalence in those with above optimal BP at 18 months compared with those receiving advice alone—22% versus 32%; odds ratio, OR 0.77 (95% CI 0.62-0.97) [5]. Antihypertensive pharmacotherapy reduces the relative risk of myocardial infarction by 20% to 25%, stroke by 30% to 40%, and heart failure by nearly 50% [6].

    Guidelines consistently recommend regular home BP monitoring for HTN management, particularly in patients with established HTN, comorbid diabetes or chronic kidney disease, suspected nonadherence, and white coat or masked HTN [7-10]. Although these recommendations are based on weak evidence and expert opinion, a recent systematic review and meta-analysis found that home BP monitoring for 6 months leads to a significant decline in systolic blood pressure (SBP) by 3.9 and diastolic blood pressure (DBP) by 2.4 mmHg versus usual care [11]. Home BP telemonitoring is also associated with larger reductions in office (SBP 4.7 mmHg, DBP 2.5 mmHg) and ambulatory BP versus usual care [12]. Recent guidelines suggest that home BP monitoring may also be used in the diagnosis of HTN [10,13-15].

    Health interventions using mobile technology, that is, mobile health (mHealth), are increasingly used to provide patients and health care professionals with additional tools and resources to manage chronic disease [16], including HTN [17-20]. For example, a systematic review found that digital health interventions significantly reduced cardiovascular disease outcomes in primary and secondary prevention populations (relative risk 0.61; 95% CI 0.46-0.80, I2=22%) but had no influence on SBP (−1.18 mmHg, 95% CI −2.93 mmHg to 0.57 mmHg, I2=100%) [18]. In contrast, a small study using a mobile-based self-management support system significantly reduced systolic (−7 mmHg) and diastolic (−4.9 mmHg) BP over 8 weeks [21]. Furthermore, a mobile phone–based medication reminder app improved adherence and BP among patients with HTN [19]. Therefore, mHealth apps may serve to enhance BP control in patients with HTN by providing a flexible, convenient platform for patient self-management.

    Rationale and Objective

    Assessing the content and quality of medical apps designed for consumers may help clinicians recommend reliable and accurate apps as well as promote safe app use by patients, but only 1 published study has previously evaluated HTN apps [22-25]. In 2014, Kumar et al conducted a content analysis of the functional characteristics and consumer interaction metrics for the top 107 HTN-related apps for Apple iPhone and Google Android devices [25]. They reported that a majority of apps are designed to track BP, weight, or body mass index and concluded that greater oversight is needed in medical HTN app development, especially apps qualifying as medical devices. However, they did not conduct a formal evaluation of the quality and usefulness of the BP tracking functionalities, for example, whether available apps allow tracking of duplicate home measurements every morning and evening over a 7-day period with calculation of mean BP excluding the first day readings for clinical decision making as recommended by experts [15,26-29].

    To address this gap and assist both clinicians and patients in selecting high-quality apps that could be used in the diagnosis and management of HTN, our objective was to develop a content-dependent rating system for BP tracking apps and to systematically evaluate the BP tracking features, content-independent quality, functional characteristics, and educational comprehensiveness of currently available English language iPhone apps developed with the primary purpose of tracking a consumer’s home BP measurements.


    Methods

    Criteria for Assessment of Blood Pressure Tracking Apps

    We used several international HTN clinical practice guidelines statements [26-29] and the systematic review of asthma self-management apps by Huckvale et al to guide development of criteria and domains for our BP tracking app evaluation tool (Table 1; Multimedia Appendix 1) [30,31].

    Table 1. Features of the reviewed apps (N=62).
    View this table
    Blood Pressure Tracking Features

    BP tracking features were evaluated in 6 areas regarding the following abilities: to record duplicate morning and evening measurements for at least one week, set a BP goal, set reminders to take BP readings, sync data with a home BP monitor, backdate and time stamp readings, and log personal notes with each reading.

    Blood Pressure Data Validation

    BP pressure data validation was assessed using 2 items: presence of rational minimum and maximum BP limits (scrolled data entry) or warning about improbably low or high readings (typed in readings), and warning about inverted entry of systolic and diastolic readings.

    Blood Pressure Analytical Features

    BP analytical features were assessed in 7 areas regarding the following abilities: to conduct in-app statistical analysis including mean BP readings, perform in-app graphing of BP measurements, categorize BP readings and red flag abnormal readings, suggest an appropriate course of action for readings in alert ranges, export data for sharing with others, automatically share readings, and perform cloud-based data backup. The app evaluation tool awarded 1 point for positive responses and 0 points for negative responses, for most items. Some items were scaled on 2-, 3-, or 4-point scales according to the level of functionality present (Multimedia Appendix 1).

    Content Independent Health on the Net Quality

    The quality of all apps was assessed using modified content-independent criteria created by the Health on the Net (HON) Foundation and used by Huckvale et al [30-32]. The 8 items were adapted to focus on BP tracking apps and included whether or not the app included a health care professional, as defined by the Health Professions Act on the authorship and development team, a clear purpose or disclaimer that it is not meant to replace the advice of a health care professional, a privacy policy, a recent update (ie, an update in the past 12 months), BP categories referenced using scientific literature, contact information for the app developers, a sponsorship statement and clear labeling of sponsors, and finally, a clear distinction between advertising, if present, and content. One point was awarded for positive responses and 0 points were awarded for negative responses.

    Functional Characteristics

    Functional characteristics were rated according to 13 items including the presence of a BP log, heart rate log, symptoms log, and cardiovascular risk calculator; trackers for exercise, diet, dietary sodium, weight, medication, and lab values (eg, sodium, potassium, serum creatinine); compatibility with social media platforms and presence of built-in educational material or referral to outside resources for HTN education.

    Apps Containing Educational Material

    For apps that combined BP logging features with health information, the information in these apps was assessed in 2 domains: comprehensiveness and consistency with evidence-based guidelines.

    Comprehensiveness

    We assessed 7 topics, whether the app contained information on BP basics, treatment options, how to use treatments, BP self-monitoring technique, a personalized action plan, how to recognize abnormal BP values, and links to health care providers. For each topic, coverage was assessed as Present in entirety (2 points), Partial (1 point), or Not present (zero points).

    Consistency

    We extracted key messages that were consistent among 3 international guidelines regarding BP measurement techniques (7 items) and lifestyle management (6 items) [14,26,33]. One point was awarded for information consistency and 0 points for information inconsistency, with selected statements.

    Home Blood Pressure Monitoring Best Practices

    Finally, given the complexity of the proposed 28-item evaluation tool, we evaluated each app against a 2-item home BP monitoring best practices criterion as suggested in major clinical practice guidelines [27-29]. Apps that allowed input of duplicate BP readings in the am and pm for at least seven days and contained in-app statistical analysis, allowing for calculation of mean BP values on user-specified dates, were deemed to meet this criterion [26-29].

    A mock patient and predefined set of tasks was developed to ensure consistent, comprehensive evaluation of each app (Multimedia Appendix 2). Our full assessment form went through several iterations and rounds of testing before it was fully implemented in the review.

    Search Strategy

    In total, 2 search terms, hypertension and blood pressure, were used to identify English language apps focused on tracking serial BP measurements for adult members of the general public or HTN patients available in the Canadian Apple App Store. A preliminary search was conducted between May 22, 2015, and July 28, 2015, (AL) using an Apple iPad model MC769C/A, iOS version 8.4, and the final search was conducted on June 28, 2016, by a second investigator (MJM) using an Apple iPhone 7, iOS version 10.3.2, from Edmonton, Alberta, Canada.

    App Selection and Data Extraction

    Apps were included if the title or the app description indicated that the primary function of the app was to track BP measurements over time, the app was intended for use by the general public or HTN patients, was in English, and available in Canada. Preliminary searching indicated a large number of potentially relevant apps. Rather than limit our search to the top 50 apps as done by others [25], we narrowed the scope of the review to apps that focused on BP tracking for uncomplicated HTN. Therefore, we excluded apps advertised as whole health trackers where BP was only 1 of several tracked parameters and those that focused on HTN in the context of comorbid diabetes, chronic kidney disease, or other chronic health conditions. We excluded apps that required the purchase of a proprietary BP monitor as the only means to enter BP readings into the app. Both paid and free apps were analyzed, but when both free and paid versions were available, only free versions of apps were analyzed. Finally, we excluded apps that contained 2 or more technical or functional errors that made the app unusable and apps costing more than Can $19.99.

    App name, developer, and cost were extracted for all apps by a single reviewer (MJM). Subsequently, a 2-phase screening process was completed independently by both reviewers. The first screen was based on the information provided in the App Store summary and any linked webpages. The second screen was conducted on the basis of the information in the app after it was downloaded. In cases of disagreement, a third party was asked to assess the App Store summary, and an agreement was reached by consensus. All apps that passed the screening process had the following descriptive information recorded from the App Store: category, date of last update, version, parental rating, original release date, current version, and average user star rating.

    Statistical Analysis

    We calculated the scores for each respective domain by summing the individual response scores for each component. The usefulness of an app’s BP tracking functionality was calculated as the sum of the BP tracking features, BP data validation, and BP analytical features domain scores. We summed the usefulness score with the HON quality score to create the app overall quality score.

    We analyzed measures of central tendency for all variables and scores. Parametric data were presented as mean (SD), whereas nonparametric data were presented as median (interquartile range, IQR). We explored whether paid apps were of higher quality than free apps, whether apps with an educational component were of higher quality than those without an educational component, and whether apps with user star ratings ≥4 were of higher overall quality than those rated less than 4 stars or without a rating. Two-tailed Mann Whitney U or 2 independent sample t tests were used as appropriate to compare median domain scores and mean overall quality scores between groups. All data were extracted to Microsoft Excel for Mac 2011 (Microsoft Corp), and statistical analysis was conducted using SPSS (IBM SPSS Statistics for Mac, Version 24.0, IBM Corp).


    Results

    Characteristics of Included Apps

    Of the 948 apps screened, 62 (6.5%) met the inclusion criteria (Figure 1). A majority of apps were excluded as they were deemed not relevant to HTN tracking (41.0%; 389/948), they were no longer available for download when the assessment started in May 2017 (13.4%; 127/948), or they were duplicate records (12.1%; 115/948). Of note, several apps with BP tracking functionality were excluded (n=79 whole health monitors; n=43, which required automated transmission of data from a BP monitor; n=27, which were diabetes apps centered on blood glucose tracking; n=17, which were no longer functional; n=1, which cost more than Can $19.99; Figure 1).

    Characteristics of the included apps are shown in Table 1. In total, 24 apps required payment and had an average cost of Can $2.54 (SD 1.10). Of the 38 free apps, 18 had an option to upgrade to a paid version/offered in-app purchases. All included apps were categorized as medical or health and fitness apps. Only 19% (12/62) of included apps had a user rating for the current version, and only 8% (5/62) were rated as ≥4 stars. The identified apps were most commonly created in the United States (23%; 14/62) and Germany (13%; 8/62). Most apps were sponsored by/created by a software company (53%; 34/62), an individual person (33%; 20/62), or a medical device company (9%; 6/62). A list of all the included apps is available in Multimedia Appendix 3.

    Figure 1. Flow diagram. BP: blood pressure.
    View this figure

    Overall Quality Score and Adherence With Home Blood Pressure Monitoring Best Practice Criteria

    The mean overall quality score was 12.5 (SD 4.8) out of 28, and it ranged from 2 to 22 (Table 2). In total, 10% (6/62) of included apps met the proposed home BP monitoring best practice criteria.

    Usefulness of Blood Pressure Tracking Functions

    The mean BP tracking usefulness score was 9.7 (SD 3.7) out of 20 (Table 2). The mean BP tracking features domain score was 3.7 (SD 1.6) out of 7, and as shown in Table 1, most apps allowed for the entry of duplicate measures in the morning/evening for 7 days (79%; 49/62), or they allowed backdating of inputted measures (86%; 53/62), whereas a few allowed BP goal setting (19%; 12/62), reminders (32%; 20/62), or allowed automated entry of BP readings (19%; 12/62). The mean data validation domain score was 0.7 (SD 0.7; Table 2) and 47% (29/62) had rational maximum and minimum BP limits, whereas only 26% (16/62) flagged inverted systolic and diastolic BP readings. The mean analytic features domain was 5.3 (SD 2.3; Table 2). Although 58% (36/62) of the apps allowed in-app analysis of BP readings, only 10% (6/62) allowed for in-app calculation of average BP readings using user dates (Table 1). Most allowed for in-app graphing of BP readings (89%; 55/62), data export (81%; 50/62), or categorization of BP measurements (66%; 41/62), whereas only 8% (5/62) suggested an appropriate course of action when BP readings were in alert ranges.

    Table 2. Hypertension app scores for functionality, usefulness, and quality (n=62).
    View this table

    Health on the Net Quality Scores

    The median HON quality score was low (2, IQR 1-4 out of 8, Table 2). As shown in Table 1, just under half (45%; 28/62) of the apps were updated in the past year, contained a privacy policy (44%; 28/62), had contact details or support (55%; 33/62), and had clearly labeled sponsorships (45%; 28/62). A minority had health care professional involvement, a disclaimer, and references to scientific research for BP ranges. Only 15% (9/62) referenced scientific literature for the BP category cut-offs used.

    Functional Characteristics

    The median number of functional characteristics was 2.5 (IQR 2-4, Table 2). Most apps had at least one additional feature beyond BP and heart rate tracking (53%; 33/62). Most common were weight tracking (34%; 21/62), educational content (18%; 11/62), or medication tracking (18%; 11/62; Table 1). Although 1 app had 9 different functions, few apps (26%; 16/62) had 4 or more built-in functions.

    Apps Containing Educational Material

    The median educational comprehensiveness in the 12 apps that contained educational content was 2 (IQR 1.5-2) out of 14 (Table 2). Most apps contained basic information about BP and HTN (75%; 9/12), lifestyle management options (58%; 7/12), and encouraged sharing of BP readings with health care professionals (42%; 5/12), whereas few (25%; 3/12) provided information about BP measurement technique (Table 3).

    Table 3. Assessment of apps containing educational content.
    View this table

    Exploring Influence of Cost, Educational Content, and User Rating

    There were no statistically significant differences in functional characteristics, usefulness, HON quality, or overall quality between free and paid apps (Table 4). Apps with an educational component had higher overall quality scores than those without an educational component (mean 15.1, SD 3.8 vs 11.8, SD 4.8; P=.03). Although only 5 apps were rated ≥4 stars, those with this rating had a higher overall quality score (median 19, IQR 15-20, vs 12, IQR 9-15; P=.02). These appeared to be driven by both higher usefulness and HON quality scores.

    Table 4. Comparison of hypertension app domain and overall quality scores by cost, presence of educational content, and user rating (n=62).
    View this table

    Discussion

    Principal Findings

    In this review, we found concerning gaps in BP tracking features and large variation in the overall quality of the 62 reviewed apps according to the evaluation tool that we developed. In total, only 6 apps met the home BP measurement best practice criteria, and although most apps allowed the entry of duplicate BP measures in the morning and evening, most did not allow for in-app statistical analysis on the basis of user-specified rather than preset fixed dates based on the date of accessing the app. Of note, no apps automatically calculated the mean BP value on the basis of the last 6 days of readings, as recommended by some organizations, and only apps that allowed users to specify the dates included allowed this calculation. Few apps flagged readings that were incorrectly input as diastolic over systolic, or they suggested an appropriate course of action when BP readings were in alert ranges. In addition, most apps used reference BP ranges set in the Joint National Committee 6 or 7 reports on HTN, which were based on office readings and none were based on the new 2017 American College of Cardiology/American Heart Association hypertension guideline [7,15]. Although some apps allowed for customization of BP target values, the treatment targets were defined on the basis of in-office measures. The content-independent HON quality was low, with the majority scoring poorly on these criteria. None of the included apps included the ability to turn the iPhone into a medical device, and although 6 apps were designed for use with a specific brand of BP monitor, none of the reviewed apps connected with a Hypertension Canada-endorsed BP monitor.

    Few of the reviewed apps contained educational content, and in those that did, the materials were not comprehensive. Educational material generally focused on the basic BP background information or treatment options. Most apps were lacking key information on BP measurement technique, and none advocated the use of validated BP measurement devices, duplicate readings twice per day for 7 days, and use of an appropriately sized cuff.

    We found that apps with an educational component or an App Store rating ≥4 stars were of higher overall quality compared with those without an educational component or ≤3 stars. Despite this, only 5 out of the top 10 overall quality apps and only 1 of the 6 apps meeting the best practice criteria had star ratings. On the basis of this, we suggest the use of a simplified ranking system that is not only primarily based on consistency with home BP monitoring best practice criteria but also takes into consideration the presence of educational material on BP measurement and the App Store rating (Textbox 1). Such a tool may be directly helpful for clinicians in making recommendations to patients or others regarding BP tracking apps.


    Textbox 1. Proposed simplified, content-dependent criteria to evaluate blood pressure-tracking app quality.
    View this box

    Strengths and Limitations

    Our study has several strengths, including a comprehensive search to identify all relevant BP tracking apps for the iOS platform, a rigorous app assessment process based on best practices from the app evaluation literature [22], and a duplicate review of all apps by independent investigators [22]. Despite the strengths, there are several limitations. First, we did not review BP tracking apps designed for the Android platform; therefore, we are potentially missing a significant number of unique apps developed exclusively for this platform. Data from 2017 suggest that approximately 46% and 43% of the smartphone market share was held by Android devices in Canada and the United States, respectively [34]. Although Kumar et al found no overlap in the top 5 most popular HTN apps by the number of downloads for iPhone and Android, there was a large degree of overlap in apps identified in Apple iTunes for iPhone and Google Play Store [25]. Second, we could only access the Canadian Apple App Store, and therefore we may not have captured apps available in other countries. Despite this, our review is applicable to clinicians internationally as we have provided both a detailed and simplified content-dependent app ranking system, the latter of which is directly applicable to clinicians in recommending useful home BP monitoring apps, regardless of the country. Third, by excluding apps that absolutely required automated transmission of data from a smart BP monitor to populate data into the app (eg, those from Withings, Qardioarm, and iHealth), excluding apps that were focusing on comorbid chronic conditions or were whole-health monitors, our results primarily reflect a specific subset of manual BP tracking apps available in the iOS market before the widespread availably of smart BP monitors. Automated smart BP monitors that have the ability to automatically populate data from a connected BP monitor into an app may score higher on our assessments. Although multimorbidity is common in primary care, and patients with HTN commonly have other manifestations of coronary heart disease or other chronic conditions [35], we feel justified in excluding these types of apps, as it was felt that consumers wanting to find an app to track their BP would preferentially pick 1 that did so as its primary function. In addition, by excluding apps focused on diabetes, we avoided issues associated with the controversy surrounding BP treatment targets [36]. Although we did not see major differences in paid and free apps, limiting our review to free versions of apps with a paid version may have artificially biased the usefulness and quality scores in a downward direction. Fourth, the recommendations for evaluation of mobile phone apps continue to evolve [23], and we did not use newer validated app-rating scales such as the Mobile Application Rating Scale [37]. However, our 2-item assessment tool using home BP monitoring best practice criteria was based on expert consensus recommendations from major organizations like Hypertension Canada and the American College of Cardiology/American Heart Association, which advocate for recording duplicate BP measures twice daily for at least seven days and using the mean home BP value to diagnose HTN in relation to a cut-off SBP ≥135 mmHg or DBP ≥85 mmHg [15,26,38]. Fifth, given the dynamic nature of apps in terms of content, updates, and changes in availability, the overall app quality scores and any recommendations regarding the use of specific apps are subject to change as apps are updated, new apps are released, and others are removed. Finally, by not involving patients in the app review, important components that may impact effective app use and usability (ie, limited health or technological literacy) were not systematically assessed in our review.

    Comparison With Earlier Work

    The only other review of HTN self-management apps was performed by Kumar et al, who performed a content analysis of the top 50 apps for HTN for Android and iOS devices [25]. They found that 72% contained a tracking function, 22% had tools to enhance medication adherence, 37% contained general information on HTN, and 8% contained information on the DASH diet. In addition, they found that only 3% of the apps were developed by health care agencies (ie, universities or professional organizations). In contrast, our review only focused on patient-oriented apps that contained BP tracking functions and found that in these apps, 35% contained adherence tools and 18% had built-in educational content. We also found that only a minority of available apps were developed by health care agencies. Kumar et al found that the ability of apps to track BP was significantly associated with the number of app downloads. We did not explore this relationship as Apple does not release iOS app download statistics.

    Our finding of a broad variation in the app quality is consistent with previous reviews of health-related mobile phone apps in the areas of diabetes, smoking cessation, pain and pulmonary management. Demidowich et al found that only 4 of 42 Android apps targeted toward diabetes self-management had sufficiently high composite usability scores, which suggested that few apps provided a comprehensive method of diabetes management [39]. In our study, only 7 apps had overall quality scores ≥19 and only 6 met the best practices criteria. Our adapted HON quality score results are similar to those of Huckvale et al, who found a generally low quality of asthma self-management apps using the HON criteria [30]. In our data, it appeared as though user star ratings may be helpful to identify a quality app, but these data are not robust, and others have found poor correlation between user-star ratings and app usability scores [39].

    This study found only 12 apps that contained any sort of educational component, with no app scoring above 50% for educational quality. This demonstrates that these apps were primarily designed to be tracking tools, with little emphasis on comprehensive, high-quality educational material. Similarly, Abroms et al documented that few smoking cessation iPhone apps adhered to key guidelines and provided recommendations or linked users to proven treatments, such as pharmacotherapy, counseling, and/or quit lines [40]. Huckvale et al evaluated 103 asthma self-management apps, 38 of which contained an educational component [30]. Similar to their study, no HTN app addressed all aspects of the guidelines. In their updated 2015 study just over half (57%; 83 of 147) of apps provided educational information about asthma [31]. Therefore, it appears that asthma apps have more robust, evidence-based chronic disease self-management information than apps designed for BP tracking.

    Conclusions

    A handful of apps explicitly developed and marketed for BP tracking are adherent to home BP monitoring best practices, as set out by clinical practice guidelines, and score highly on overall quality. However, several concerning gaps exist in the current BP tracking apps. Although app store ratings and the presence of educational content may help clinicians or patients choose higher quality apps, many high-quality apps did not have consumer ratings. At minimum, we suggest clinicians should evaluate whether a BP tracking app allows input of duplicate BP readings for at least seven days and presents the mean BP value for user-specified dates. There remain opportunities to improve the overall quality of patient-focused BP tracking apps and incorporate evidence-based HTN education to further optimize patient self-management of HTN.

    Acknowledgments

    The investigators wish to thank the Rx&D Health Research Foundation Summer studentship and the Lawson Foundation (Grant number GRT 2012-057) for supporting this work. We also wish to acknowledge Ms. Darlene Korn, currently a clinical pharmacist with Alberta Health Services, for assisting with the early phases of app evaluation, which occurred in 2012 to 2013, and Dr. Ann Thompson, Clinical Associate Professor, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, for acting as the third-party adjudicator.

    Authors' Contributions

    AL and MM contributed to conception and design. AL and MM contributed to acquisition of data, analysis, and interpretation. AL prepared the first draft of the manuscript. Critical revision of manuscript for intellectual content was done by AL and MM. Final approval of the version to be published was granted by AL and MM.

    Conflicts of Interest

    MM owns stock in Apple Corporation but has no financial stock or interests in any of the reviewed Apps. AL declares no conflicts of interest.

    Multimedia Appendix 1

    Criteria for app assessment.

    PDF File (Adobe PDF File), 148KB

    Multimedia Appendix 2

    Mock patient used for app evaluation.

    PDF File (Adobe PDF File), 83KB

    Multimedia Appendix 3

    List of included apps.

    PDF File (Adobe PDF File), 84KB

    References

    1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016 Aug 09;134(6):441-450. [CrossRef] [Medline]
    2. Padwal RS, Bienek A, McAlister FA, Campbell NRC, Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 2016 Dec;32(5):687-694. [CrossRef] [Medline]
    3. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 Dec 15;380(9859):2224-2260 [FREE Full text] [CrossRef] [Medline]
    4. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016 Oct 08;388(10053):1659-1724 [FREE Full text] [CrossRef] [Medline]
    5. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006 Apr 4;144(7):485-495. [Medline]
    6. Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. Br Med J 2008 May 17;336(7653):1121-1123 [FREE Full text] [CrossRef] [Medline]
    7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003 May 21;289(19):2560-2572. [CrossRef] [Medline]
    8. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 2014 Jan;16(1):14-26 [FREE Full text] [CrossRef] [Medline]
    9. Go AS, Bauman MA, Coleman KSM, Fonarow GC, Lawrence W, Williams KA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol 2014 Apr 01;63(12):1230-1238 [FREE Full text] [CrossRef] [Medline]
    10. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Hypertension Canada. Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol 2018 May;34(5):506-525. [CrossRef] [Medline]
    11. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med 2013 Aug 6;159(3):185-194. [CrossRef] [Medline]
    12. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013 Mar;31(3):455-467. [CrossRef] [Medline]
    13. National Institute of Health and Clinical Excellence. Hypertension in adults: diagnosis and management   URL: https://www.nice.org.uk/guidance/cg127 [accessed 2019-02-25] [WebCite Cache]
    14. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013 Jul;31(7):1281-1357. [CrossRef] [Medline]
    15. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2017 Nov 13;71(6):e13-155. [CrossRef] [Medline]
    16. Silva BM, Rodrigues JJ, de la Torre Díez I, López-Coronado M, Saleem K. Mobile-health: a review of current state in 2015. J Biomed Inform 2015 Aug;56:265-272 [FREE Full text] [CrossRef] [Medline]
    17. Logan AG. Transforming hypertension management using mobile health technology for telemonitoring and self-care support. Can J Cardiol 2013 May;29(5):579-585. [CrossRef] [Medline]
    18. Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc 2015 Apr;90(4):469-480. [CrossRef] [Medline]
    19. Patel S, Jacobus-Kantor L, Marshall L, Ritchie C, Kaplinski M, Khurana PS, et al. Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. J Diabetes Sci Technol 2013 May 01;7(3):630-639 [FREE Full text] [CrossRef] [Medline]
    20. Omboni S, Caserini M, Coronetti C. Telemedicine and m-health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev 2016 Sep;23(3):187-196. [CrossRef] [Medline]
    21. Bengtsson U, Kjellgren K, Hallberg I, Lindwall M, Taft C. Improved blood pressure control using an interactive mobile phone support system. J Clin Hypertens (Greenwich) 2016 Feb;18(2):101-108 [FREE Full text] [CrossRef] [Medline]
    22. BinDhim NF, Hawkey A, Trevena L. A systematic review of quality assessment methods for smartphone health apps. Telemed J E Health 2015 Feb;21(2):97-104. [CrossRef] [Medline]
    23. McKay FH, Cheng C, Wright A, Shill J, Stephens H, Uccellini M. Evaluating mobile phone applications for health behaviour change: a systematic review. J Telemed Telecare 2016 Oct 18;24(1):22-30. [CrossRef] [Medline]
    24. Parati G, Torlasco C, Omboni S, Pellegrini D. Smartphone applications for hypertension management: a potential game-changer that needs more control. Curr Hypertens Rep 2017 Jun;19(6):48. [CrossRef] [Medline]
    25. Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens 2015 Feb;9(2):130-136. [CrossRef] [Medline]
    26. Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2015 May;31(5):549-568. [CrossRef] [Medline]
    27. Celis H, Den Hond E, Staessen JA. Self-measurement of blood pressure at home in the management of hypertension. Clin Med Res 2005 Feb;3(1):19-26 [FREE Full text] [Medline]
    28. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion J, Mancia G, European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003 May;21(5):821-848. [CrossRef] [Medline]
    29. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004 Mar;18(3):139-185. [CrossRef] [Medline]
    30. Huckvale K, Car M, Morrison C, Car J. Apps for asthma self-management: a systematic assessment of content and tools. BMC Med 2012 Nov 22;10:144 [FREE Full text] [CrossRef] [Medline]
    31. Huckvale K, Morrison C, Ouyang J, Ghaghda A, Car J. The evolution of mobile apps for asthma: an updated systematic assessment of content and tools. BMC Med 2015;13:58 [FREE Full text] [CrossRef] [Medline]
    32. Health on the Net Foundation. The commitment to reliable health and medical information on the internet   URL: http://healthonnet.org/HONcode/Pro/Visitor/visitor.html [accessed 2017-09-11] [WebCite Cache]
    33. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008 Aug;26(8):1505-1526. [CrossRef] [Medline]
    34. Device Atlas. Android v iOS market share 2019   URL: https://deviceatlas.com/blog/android-v-ios-market-share [accessed 2019-02-25] [WebCite Cache]
    35. Guthrie B, Payne K, Alderson P, McMurdo ME, Mercer SW. Adapting clinical guidelines to take account of multimorbidity. Br Med J 2012 Oct 04;345:e6341. [Medline]
    36. Rabi DM, Padwal R, Tobe SW, Gilbert RE, Leiter LA, Quinn RR, Canadian Hypertensive Education Program, Canadian Diabetes Association. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes. Can Med Assoc J 2013 Aug 06;185(11):963-967 [FREE Full text] [CrossRef] [Medline]
    37. Stoyanov SR, Hides L, Kavanagh DJ, Zelenko O, Tjondronegoro D, Mani M. Mobile app rating scale: a new tool for assessing the quality of health mobile apps. JMIR Mhealth Uhealth 2015;3(1):e27 [FREE Full text] [CrossRef] [Medline]
    38. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med 2015 Nov 03;163(9):691-700 [FREE Full text] [CrossRef] [Medline]
    39. Demidowich AP, Lu K, Tamler R, Bloomgarden Z. An evaluation of diabetes self-management applications for Android smartphones. J Telemed Telecare 2012 Jun;18(4):235-238. [CrossRef] [Medline]
    40. Abroms LC, Padmanabhan N, Thaweethai L, Phillips T. iPhone apps for smoking cessation: a content analysis. Am J Prev Med 2011 Mar;40(3):279-285 [FREE Full text] [CrossRef] [Medline]


    Abbreviations

    BP: blood pressure
    DASH: Dietary Approaches to Stop Hypertension
    DBP: diastolic blood pressure
    HON: Health on the Net
    HTN: hypertension
    IQR: interquartile range
    mHealth: mobile health
    SBP: systolic blood pressure


    Edited by G Eysenbach; submitted 18.04.18; peer-reviewed by N Kumar, S Ong, S Omboni; comments to author 07.08.18; revised version received 02.01.19; accepted 26.01.19; published 12.04.19

    ©Amanda Y Leong, Mark J Makowsky. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 12.04.2019.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.